Links between patients' perception of research activities and hospitals' attractiveness

Article Sidebar

Requires Subscription or Fee PDF (USD 25)
Published: Dec 6, 2012
DOI: https://doi.org/10.5750/ijpcm.v2i4.309
Keywords:
Cancer clinical epidemiology clinical trials haematological malignancies hospitals’ attractiveness person-centered care referral

Main Article Content

Julien Mancini
Aix-Marseille Université, Inserm, IRD, UMR912, SESSTIM, “Cancers, Biomedicine & Society” Team and APHM, Timone Hospital, Public Health Department, Marseille
Claire Julian-Reynier
Aix-Marseille Université, Inserm, IRD, UMR912, SESSTIM, “Cancers, Biomedicine & Society” Team and Institut Paoli-Calmettes, Marseille
Isabelle Pellegrini
Aix-Marseille Université, Inserm, IRD, UMR912, SESSTIM, “Cancers, Biomedicine & Society” Team
Norbert Vey
Aix-Marseille Université, Inserm, CNRS, UM105, CRCM and Institut Paoli- Calmettes, Marseille
Lise-Marie Billard-Daufresne
Aix-Marseille Université, Inserm, CNRS, UM105, CRCM and Institut Paoli- Calmettes, Marseille
Dominique Genre
Aix-Marseille Université, Inserm, CNRS, UM105, CRCM and Institut Paoli- Calmettes, Marseille
Anthony Gonçalves
Aix-Marseille Université, Inserm, CNRS, UM105, CRCM and Institut Paoli- Calmettes, Marseille
Patrice Viens
Aix-Marseille Université, Inserm, CNRS, UM105, CRCM and Institut Paoli- Calmettes, Marseille
Christian Chabannon
Aix-Marseille Université, Inserm, CNRS, UM105, CRCM and Institut Paoli- Calmettes, Marseille

Abstract

Rationale, aims and objectives: The possibility of having access to clinical trials and investigational drugs and procedures may be regarded by patients as an attractive opportunity. However, medical research can also be negatively perceived by patients who are afraid of being used for experimental purposes. The objective of this study was therefore to investigate patients’ perception of the research activities conducted in a comprehensive cancer centre and their relation with hospital attractiveness.Method: In depth interviews (n=19) were conducted before a postal survey (n=745) on adult patients recently treated for colorectal or breast cancer or a haematological malignancy at a French regional comprehensive cancer centre.Results: Among 574 patients (response rate = 77.0%), 51.2% declared that their knowledge of research activities conducted at this hospital influenced their decision to attend this institution. Most of the patients (85.7%) said they would recommend the hospital to friends and relatives. This response was more frequent among patients (74.7%) who associated research activities with high quality care (adjusted odds ratio [adjOR] = 2.41, 95% Confidence Interval = 1.27 to 4.56) and less frequent among those (29.6%) who said they had never or not often enough been asked to participate in research (adjOR = 0.51, 95% CI= 0.28 to 0.96), whatever their socio-demographics, cancer characteristics, previous clinical trial participation and satisfaction with care.Conclusion: Developing visible, understandable research activities was positively perceived by patients and increased hospitals’ attractiveness.

Article Details

Issue
Vol. 2 No. 4 (2012)
Section
Regular Articles

References

Oliveria, S.A., Yood, M.U., Campbell, U.B., Yood, S.M. & Stang, P. (2004). Treatment and referral patterns for colorectal cancer. Medical Care 42 (9) 901-906.

Neugut, A.I. & Grann, V.R. (2002). Referral to medical oncologists: are there barriers at the gate? Journal of Clinical Oncology 20 (7) 1716-1718.

Moatti, J.P., Le Corroller Soriano, A.G. & Protiere, C. (2003). Le Plan Cancer en France : une reflexion d'economistes. Bulletin du Cancer 90 (11) 1010-1015.

Timmermans, S. & McKay, T. (2009). Clinical trials as treatment option: bioethics and health care disparities in substance dependency. Social Science and Medicine 69 (12) 1784-1790.

Mancini, J., Pellegrini, I., Viret, F., Vey, N., Daufresne, L.M., Chabannon, C. & Julian-Reynier, C. (2011). Consent for biobanking: assessing the understanding and views of cancer patients. Journal of the Nationall Cancer Institute 103 (2) 154-157.

Stevens, T. & Ahmedzai, S.H. (2004). Why do breast cancer patients decline entry into randomised trials and how do they feel about their decision later: a prospective, longitudinal, in-depth interview study. Patient Education and Counselling 52 (3) 341-348.

Wright, J.R., Whelan, T.J., Schiff, S., Dubois, S., Crooks, D., Haines, P.T., DeRosa, D., Roberts, R.S., Gafni, A., Pritchard, K. & Levine, M.N. (2004). Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision. Journal of Clinical Oncology 22 (21) 4312-4318.

Quinn, G.P., Bell, B.A., Bell, M.Y., Caraway, V.D., Conforte, D., Graci, L.B., Powell-Stafford, V.L., Sapp, A.L., Shimizu, C.O., Vaughn, E.J., Williams, C. & Bepler, G. (2007). The guinea pig syndrome: improving clinical trial participation among thoracic patients. Journal of Thoracic Oncology 2 (3) 191-196.

Weinfurt, K.P., Friedman, J.Y., Allsbrook, J.S., Dinan, M.A., Hall, M.A. & Sugarman, J. (2006). Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure. Journal of General Internal Medicine 21 (9) 901-906.

Tournois, J., Mesnil, F. & Kopp, J. L. (2000). Autoduperie et hétéroduperie : un instrument de mesure de la désirabilité sociale. Revue Européenne de Psychologie Appliquée 50 (1) 219-232.

Siminoff, L.A., Zhang, A., Saunders Sturm, C.M. & Colabianchi, N. (2000). Referral of breast cancer patients to medical oncologists after initial surgical management. Medical Care 38 (7) 696-704.

Denberg, T.D., Melhado, T.V. & Steiner, J.F. (2006). Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote. Cancer 107 (3) 620-630.

Greenberg, E.R., Dain, B., Freeman, D., Yates, J. & Korson, R. (1988). Referral of lung cancer patients to university hospital cancer centers. A population-based study in two rural states. Cancer 62 (8) 1647-1652.

Minasian, L.M. & O'Mara, A.M. (2011). Accrual to clinical trials: let's look at the physicians. Journal of the National Cancer Institute 103 (5) 357-358.

Purdy, S., Finkelstein, J.A., Fletcher, R., Christiansen, C. & Inui, T.S. (2000). Patient participation in research in the managed care environment: key perceptions of members in an HMO. Journal of General Internal Medicine 15 (7) 492-495.

Julian-Reynier, C., Genève, J., Dalenc, F., Genre, D., Monner, A., Kerbrat, P., Larqiller, R., Serin, D., Rios, M., Roché, H., Jimenez, M., Tarpin, C., Maraninchi, D. & Patients' Committee for Clinical Trials of the Lique Contre le Cancer. (2007). Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer. Journal of Clinical Oncology 25 (21) 3038-3044.

Jenkinson, C., Burton, J.S., Cartwright, J., Magee, H., Hall, I., Alcock, C. & Burge, S. (2005). Patient attitudes to clinical trials: development of a questionnaire and results from asthma and cancer patients. Health Expectations 8 (3) 244-252.

Sale, J.E. (2007). What do primary care nurses and radiation therapists in a Canadian cancer centre think about clinical trials? Journal of Evaluation in Clinical Practice 13 (2) 186-191.